What is CORE SCIENTIFIC INC RTS's earnings per share (EPS)?

CORE SCIENTIFIC INC RTS (CORZR) reported diluted earnings per share of -$0.88 for fiscal year 2025. This represents a 81.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CORE SCIENTIFIC INC RTS (CORZR) Financials

CORZR

Trailing 12 months to June 30, 2026

Revenue $440.3M +26.4% YoY

Net Income -$1.4B -29.2% YoY

EPS (Diluted) -$4.23 -540.9% YoY

Free Cash Flow -$957.7M -273.1% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 28, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 28, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CORZR SEC filings page.

CORE SCIENTIFIC INC RTS (CORZR) reported $440.3M in revenue over the twelve months to Jun 30, 2026, up 26.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CORZR FY2025 2026-09-05

The dominant mechanic is heavy capital reinvestment alongside shrinking revenue, with margin compression separating operating cash flow from free cash flow.

FY2025 paired a net loss of -$289M with operating cash flow of $278M, so reported cash inflow was driven by items beyond earnings rather than profitability. Yet free cash flow was -$451M as capital spending reached $729M, making reinvestment the immediate cash consumer.

Revenue contracted 37.5% in FY2025 while gross margin fell to 11.9%, indicating weaker economics accompanied the volume decline. An operating margin of -77.0% shows the cost base did not flex enough with lower sales.

Liabilities of $3.31B exceeded assets of $2.35B in FY2025, leaving the business with negative equity. Negative equity of -$963M and a current ratio of 1.1x show both long-term balance-sheet strain and a limited short-term buffer.

Financial Health Signals

Financial health score not available

CORE SCIENTIFIC INC RTS does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/8

CORE SCIENTIFIC INC RTS passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

CORE SCIENTIFIC INC RTS reported a net loss of $288.6M while generating $278.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$164.2M

YoY+108.8%

QoQ+42.5%

5Y CAGR+16.9%

CORE SCIENTIFIC INC RTS generated $164.2M in revenue in Q2 2026. This represents an increase of 108.8% from the same quarter a year earlier. Against the prior quarter it is up 42.5%.

EBITDA

-$63.1M

YoY-739.4%

QoQ+78.5%

CORE SCIENTIFIC INC RTS's EBITDA was -$63.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 739.4% from the same quarter a year earlier. Against the prior quarter it is up 78.5%.

Net Income

-$1.2B

YoY-23.3%

QoQ-232.8%

CORE SCIENTIFIC INC RTS reported -$1.2B in net income in Q2 2026. This represents a decrease of 23.3% from the same quarter a year earlier. Against the prior quarter it is down 232.8%.

EPS (Diluted)

-$3.32

QoQ-213.2%

CORE SCIENTIFIC INC RTS earned -$3.32 per diluted share (EPS) in Q2 2026. Against the prior quarter it is down 213.2%.

Cash & Balance Sheet

Free Cash Flow

-$583.9M

YoY-569.1%

QoQ-319.1%

CORE SCIENTIFIC INC RTS recorded an outflow of $583.9M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 569.1% from the same quarter a year earlier. Against the prior quarter it is down 319.1%.

Cash & Debt

$1.8B

YoY+204.4%

QoQ+76.1%

5Y CAGR+286.8%

CORE SCIENTIFIC INC RTS held $1.8B in cash against $4.3B in long-term debt as of Q2 2026.

Shares Outstanding

321M

QoQ+1.1%

CORE SCIENTIFIC INC RTS had 321M shares outstanding in Q2 2026. Against the prior quarter it is up 1.1%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

42.7%

YoY+36.3pp

QoQ+16.5pp

5Y change+10.1pp

CORE SCIENTIFIC INC RTS's gross margin was 42.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 36.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 16.5 percentage points.

Operating Margin

-47.8%

YoY-14.4pp

5Y change-68.4pp

CORE SCIENTIFIC INC RTS's operating margin was -47.8% in Q2 2026, reflecting core business profitability. This is down 14.4 percentage points from the same quarter a year earlier.

Net Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$565.0M

YoY+365.9%

QoQ+45.2%

5Y CAGR+82.0%

CORE SCIENTIFIC INC RTS invested $565.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 365.9% from the same quarter a year earlier. Against the prior quarter it is up 45.2%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

CORZR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CORZR quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Revenue	$440.3M	$319.0M-37.5%	$510.7M+1.6%	$502.4M-21.5%	$640.3M+17.6%	$544.5M	N/A
Cost of Revenue	$315.5M	$281.1M-27.8%	$389.6M+2.8%	$378.9M-40.0%	$631.9M+106.8%	$305.6M	N/A
Gross Profit	$124.8M	$37.9M-68.7%	$121.1M-1.9%	$123.5M+1369.8%	$8.4M-96.5%	$238.9M	N/A
R&D Expenses	N/A	N/A	$11.8M+64.7%	$7.2M-73.4%	$27.0M+251.3%	$7.7M	N/A
SG&A Expenses	$175.9M	$159.2M+40.0%	$113.7M+5.2%	$108.1M-49.3%	$213.3M+252.6%	$60.5M	N/A
Operating Income	-$561.2M	-$245.6M-72.9%	-$142.1M-1685.4%	$9.0M+100.4%	-$2.1B-1704.3%	$131.5M	N/A
EBITDA	N/A	-$176.7M-512.2%	-$28.9M-127.5%	$105.0M+105.6%	-$1.9B-1243.0%	$164.9M	N/A
Interest Expense	N/A	N/A	$37.1M-57.0%	$86.2M-10.9%	$96.8M+118.3%	$44.4M	N/A
Income Tax	$2.7M	$583K-32.1%	$859K+25.8%	$683K+104.0%	-$17.1M-208.4%	$15.8M	$0
Net Income	-$1.4B	-$288.6M+79.9%	-$1.4B-483.3%	-$246.5M+88.5%	-$2.1B-4636.5%	$47.3M	N/A
EPS (Basic)	N/A	-$0.88+81.9%	-$4.87-649.2%	-$0.65+89.7%	-$6.30-2839.1%	$0.23+264.3%	-$0.14
EPS (Diluted)	-$4.23	-$0.88+81.9%	-$4.87-649.2%	-$0.65	-$6.30-3250.0%	$0.20+242.9%	-$0.14
Diluted Shares (Avg)	N/A	318M+24.3%	256M-32.7%	380M	341M+46.0%	233M+48.0%	158M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$164.2M+108.8%	$115.2M+44.9%	$79.8M-16.0%	$81.1M-14.9%	$78.6M-44.3%	$79.5M-55.6%	$94.9M-33.1%	$95.4M-15.5%
Cost of Revenue	$94.2M+27.9%	$85.1M+19.4%	$59.0M-34.6%	$77.2M-19.2%	$73.6M-28.0%	$71.3M-29.8%	$90.2M-12.1%	$95.5M-2.0%
Gross Profit	$70.0M+1293.9%	$30.1M+266.6%	$20.8M+335.8%	$3.9M+2603.2%	$5.0M-87.1%	$8.2M-89.4%	$4.8M-87.9%	-$156K-101.0%
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	$5.0M+167.4%	$2.8M+26.1%
SG&A Expenses	$49.4M+9.1%	$44.8M+38.9%	$12.3M-50.9%	$69.4M+71.9%	$45.3M+44.3%	$32.3M+90.8%	$25.0M-34.9%	$40.3M+71.6%
Operating Income	-$78.5M-198.5%	-$310.4M-559.9%	-$117.5M-79.7%	-$54.8M-32.9%	-$26.3M+71.0%	-$47.0M-185.2%	-$65.4M-1762.2%	-$41.2M-242.2%
EBITDA	-$63.1M-739.4%	-$293.8M-975.8%	-$103.4M-162.7%	-$38.5M-207.0%	-$7.5M+87.7%	-$27.3M-132.4%	-$39.4M-212.0%	-$12.5M-202.8%
Interest Expense	$40.6M+755.0%	$8.2M+71.9%	N/A	N/A	$4.8M-67.8%	$4.7M-66.3%	$1.1M	$7.1M+222.0%
Income Tax	$1.9M+1107.0%	$600K+192.7%	$95K-74.7%	$125K-6.7%	$158K+9.7%	$205K-0.5%	$375K+11.6%	$134K+17.5%
Net Income	-$1.2B-23.3%	-$347.2M-160.2%	$216.0M+174.2%	-$144.0M+68.4%	-$936.8M-3.8%	$576.3M+173.5%	-$291.1M-48.8%	-$455.3M-1006.4%
EPS (Basic)	-$3.32-8200.0%	-$1.06-174.6%	$0.60+187.0%	-$0.45+61.5%	-$0.04+99.2%	$1.42+56.0%	-$0.69-32.7%	-$1.17-963.6%
EPS (Diluted)	-$3.32	-$1.06-185.5%	$0.60+187.0%	-$0.45+61.5%	-$0.04	$1.24	-$0.69-32.7%	-$1.17-963.6%
Diluted Shares (Avg)	325M	323M-11.1%	N/A	319M+8.9%	318M	363M	N/A	292M-23.5%

CORZR Balance Sheet

CORZR quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Total Assets	$2.3B+59.1%	$1.5B+107.3%	$712.2M-11.8%	$807.7M-66.9%	$2.4B+16258993.3%	$15K
Current Assets	$895.5M-0.9%	$904.0M+831.8%	$97.0M+14.0%	$85.1M-88.8%	$756.6M	N/A
Cash & Equivalents	$311.4M-62.8%	$836.2M+1558.8%	$50.4M+217.4%	$15.9M-86.5%	$117.9M	N/A
Short-Term Investments	$0	$0	$0	$0	$0	N/A
Accounts Receivable	N/A	$1.0M+2.4%	$1.0M+327.8%	$234K-83.1%	$1.4M	N/A
Long-Term Investments	$0	$0	$0	$0	$0	N/A
Goodwill	N/A	N/A	$0	$0-100.0%	$1.1B	N/A
Total Liabilities	$3.3B+36.8%	$2.4B+84.8%	$1.3B+7.6%	$1.2B+15.6%	$1.1B+1280.6%	-$89.2M
Current Liabilities	$781.4M+480.7%	$134.6M-72.4%	$488.4M+161.5%	$186.8M-41.7%	$320.3M+80072150.0%	$400
Non-Current Liabilities	$2.5B+10.7%	$2.3B+178.4%	$820.7M-20.3%	$1.0B+40.6%	$732.9M+921.5%	-$89.2M
Long-Term Debt	$1.1B	N/A	N/A	N/A	N/A	N/A
Total Equity	-$962.7M-2.1%	-$943.0M-58.0%	-$596.9M-45.8%	-$409.3M-130.5%	$1.3B+1403.2%	$89.2M
Retained Earnings	-$4.1B-7.5%	-$3.9B-59.4%	-$2.4B-11.3%	-$2.2B-7824.1%	-$27.4M-263669.2%	-$10K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$5.3B+184.1%	$3.1B+104.9%	$2.3B+59.1%	$2.2B+163.3%	$1.9B+178.6%	$1.5B+84.0%	$1.5B+107.3%	$824.6M+16.9%
Current Assets	$2.4B+143.2%	$1.5B+74.6%	$895.5M-0.9%	$1.1B+281.9%	$1.0B+752.5%	$833.2M+481.3%	$904.0M+831.8%	$277.9M+106.2%
Cash & Equivalents	$1.8B+204.4%	$1.0B+44.0%	$311.4M-62.8%	$453.4M+79.2%	$581.3M+504.8%	$697.9M+611.3%	$836.2M+1558.8%	$253.0M+500.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	$1.0M-8.0%	$1.0M+2.4%	$6.2M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$7.7B+152.3%	$4.4B+142.1%	$3.3B+36.8%	$3.4B+107.4%	$3.0B+64.9%	$1.8B+59.6%	$2.4B+84.8%	$1.7B+46.9%
Current Liabilities	$2.7B+386.5%	$2.7B+1261.5%	$781.4M+480.7%	$669.9M+775.5%	$562.7M+652.1%	$195.5M+41.5%	$134.6M-72.4%	$76.5M-75.5%
Non-Current Liabilities	$4.9B+99.2%	$1.7B+6.3%	$2.5B+10.7%	$2.8B+74.9%	$2.5B+40.1%	$1.6B+62.1%	$2.3B+178.4%	$1.6B+94.0%
Long-Term Debt	$4.3B	$1.1B	$1.1B	N/A	N/A	N/A	N/A	N/A
Total Equity	-$2.4B-103.0%	-$1.3B-322.8%	-$962.7M-2.1%	-$1.3B-51.5%	-$1.2B-0.9%	-$308.8M+3.0%	-$943.0M-58.0%	-$826.7M-97.4%
Retained Earnings	-$5.6B-33.9%	-$4.5B-36.9%	-$4.1B-7.5%	-$4.4B-22.3%	-$4.2B-35.6%	-$3.3B-48.5%	-$3.9B-59.4%	-$3.6B-60.3%

Not reported in any period shown, so not listed: Inventory, Goodwill.

CORZR Cash Flow Statement

CORZR quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Cash Flow	$520.2M	$278.3M+548.7%	$42.9M-34.1%	$65.1M-68.3%	$205.2M+461.7%	-$56.7M	N/A
Depreciation & Amortization	N/A	$68.9M-39.1%	$113.2M+17.9%	$96.0M-57.4%	$225.3M+575.2%	$33.4M	N/A
Stock-Based Compensation	N/A	$98.2M+89.2%	$51.9M-11.8%	$58.9M-67.8%	$182.9M+369.7%	$38.9M+1182.1%	$3.0M
Capital Expenditures	$1.5B	$729.0M+667.7%	$95.0M+487.6%	$16.2M-95.8%	$384.0M	$0	$0
Free Cash Flow	-$957.7M	-$450.8M-765.7%	-$52.1M-206.4%	$49.0M+127.4%	-$178.8M-215.1%	-$56.7M	N/A
Investing Cash Flow	-$1.7B	-$740.8M-678.2%	-$95.2M-3077.3%	-$3.0M+99.5%	-$590.8M-39.4%	-$423.8M	N/A
Financing Cash Flow	$3.2B	-$63.1M-107.7%	$819.6M+1935.6%	-$44.6M-114.6%	$306.2M-49.3%	$603.5M	N/A
Share Buybacks	N/A	N/A	$0	$0-100.0%	$31.6M	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$18.9M-155.7%	$249.9M+654.8%	$157.5M+1041.0%	$131.8M+2206.7%	$34.0M+2723.9%	-$45.0M-303.1%	$13.8M-36.4%	$5.7M+5.1%
Depreciation & Amortization	$15.4M-18.0%	$16.6M-15.6%	$14.1M-45.9%	$16.3M-43.1%	$18.8M-36.3%	$19.7M-32.0%	$26.0M-16.5%	$28.7M+18.4%
Stock-Based Compensation	$18.2M-24.5%	$17.8M+9.7%	N/A	$29.9M+47.6%	$24.2M+184.6%	$16.2M+1626.9%	N/A	$20.3M+36.5%
Capital Expenditures	$565.0M+365.9%	$389.2M+363.5%	$279.2M+871.0%	$244.5M+684.3%	$121.3M+3768.5%	$84.0M+163.3%	$28.8M+147.0%	$31.2M+1036.9%
Free Cash Flow	-$583.9M-569.1%	-$139.3M-8.0%	-$121.7M-714.1%	-$112.7M-342.7%	-$87.3M-4419.9%	-$129.0M-1227.4%	-$15.0M-248.7%	-$25.5M-1045.8%
Investing Cash Flow	-$796.2M-565.7%	-$386.7M-334.4%	-$277.8M-864.5%	-$254.4M-714.2%	-$119.6M-3656.5%	-$89.0M-178.4%	-$28.8M-1320.3%	-$31.2M-989.3%
Financing Cash Flow	$2.2B+7089.1%	$971.4M+23239.2%	-$21.8M-103.6%	-$5.3M-102.9%	-$31.8M-109.2%	-$4.2M-107.7%	$598.2M+3369.2%	$182.2M+1284.6%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CORZR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CORZR quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Gross Margin	11.9%-11.8pp	23.7%-0.9pp	24.6%+23.3pp	1.3%-42.6pp	43.9%	N/A
Operating Margin	-77.0%-49.2pp	-27.8%-29.6pp	1.8%	-329.5%	24.1%	N/A
Net Margin	-90.5%	-281.6%	-49.1%	-335.2%	8.7%	N/A
Return on Equity	N/A	N/A	N/A	N/A	3.5%	N/A
Return on Assets	-12.3%+85.1pp	-97.4%-62.8pp	-34.6%+231.1pp	-265.7%-267.7pp	1.9%	N/A
Current Ratio	1.15-5.6x	6.72+6.5x	0.20-0.3x	0.46-1.9x	2.36	N/A
Debt-to-Equity	N/A	N/A	N/A	N/A	0.79	N/A
Asset Turnover	0.14-0.2x	0.35-0.4x	0.71-0.1x	0.79+0.6x	0.22	N/A
FCF Margin	-141.3%	-10.2%-19.9pp	9.7%+37.7pp	-27.9%-17.5pp	-10.4%	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	42.7%+36.3pp	26.1%+15.8pp	26.0%+21.0pp	4.8%+5.0pp	6.4%-21.1pp	10.3%-33.0pp	5.0%-22.7pp	-0.2%-13.8pp
Operating Margin	-47.8%-14.4pp	-269.4%	-147.3%	-67.6%-24.3pp	-33.4%+30.8pp	-59.2%-90.0pp	-68.9%-71.7pp	-43.2%-32.6pp
Net Margin	-703.6%	-301.3%	270.8%	-177.6%	-1191.4%	724.6%	-306.7%	-477.4%
Return on Assets	-22.0%+28.6pp	-11.3%-49.8pp	9.2%+28.9pp	-6.6%+48.6pp	-50.6%+85.2pp	38.5%+12.6pp	-19.7%+7.7pp	-55.2%-49.4pp
Current Ratio	0.89-0.9x	0.55-3.7x	1.15-5.6x	1.58-2.0x	1.79+0.2x	4.26+3.2x	6.72+6.5x	3.63+3.2x
Asset Turnover	0.030.0x	0.040.0x	0.030.0x	0.04-0.1x	0.04-0.2x	0.05-0.2x	0.06-0.1x	0.120.0x
FCF Margin	-355.6%	-120.9%	-152.6%	-139.0%	-111.0%	-162.2%	-15.8%-22.8pp	-26.7%-29.1pp

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$962.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Where CORE SCIENTIFIC INC RTS Ranks

Frequently Asked Questions

What is CORE SCIENTIFIC INC RTS's annual revenue?

CORE SCIENTIFIC INC RTS (CORZR) reported $319.0M in total revenue for fiscal year 2025. This represents a -37.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CORE SCIENTIFIC INC RTS's revenue growing?

CORE SCIENTIFIC INC RTS (CORZR) revenue declined by 37.5% year-over-year, from $510.7M to $319.0M in fiscal year 2025.

Is CORE SCIENTIFIC INC RTS profitable?

No, CORE SCIENTIFIC INC RTS (CORZR) reported a net income of -$288.6M in fiscal year 2025, with a net profit margin of -90.5%.

What is CORE SCIENTIFIC INC RTS's EBITDA?

CORE SCIENTIFIC INC RTS (CORZR) had EBITDA of -$176.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does CORE SCIENTIFIC INC RTS have?

As of fiscal year 2025, CORE SCIENTIFIC INC RTS (CORZR) had $311.4M in cash and equivalents against $1.1B in long-term debt.

What is CORE SCIENTIFIC INC RTS's gross margin?

CORE SCIENTIFIC INC RTS (CORZR) had a gross margin of 11.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is CORE SCIENTIFIC INC RTS's operating margin?

CORE SCIENTIFIC INC RTS (CORZR) had an operating margin of -77.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CORE SCIENTIFIC INC RTS's net profit margin?

CORE SCIENTIFIC INC RTS (CORZR) had a net profit margin of -90.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CORE SCIENTIFIC INC RTS's free cash flow?

CORE SCIENTIFIC INC RTS (CORZR) recorded an outflow of $450.8M in free cash flow during fiscal year 2025. This represents a -765.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CORE SCIENTIFIC INC RTS's operating cash flow?

CORE SCIENTIFIC INC RTS (CORZR) generated $278.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CORE SCIENTIFIC INC RTS's total assets?

CORE SCIENTIFIC INC RTS (CORZR) had $2.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are CORE SCIENTIFIC INC RTS's capital expenditures?

CORE SCIENTIFIC INC RTS (CORZR) invested $729.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does CORE SCIENTIFIC INC RTS have outstanding?

CORE SCIENTIFIC INC RTS (CORZR) had 315M shares outstanding as of fiscal year 2025.

What is CORE SCIENTIFIC INC RTS's current ratio?

CORE SCIENTIFIC INC RTS (CORZR) had a current ratio of 1.15 as of fiscal year 2025, which is considered adequate.

What is CORE SCIENTIFIC INC RTS's return on assets (ROA)?

CORE SCIENTIFIC INC RTS (CORZR) had a return on assets of -12.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is CORE SCIENTIFIC INC RTS's debt-to-equity ratio negative or not reported?

CORE SCIENTIFIC INC RTS (CORZR) has negative shareholder equity of -$962.7M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is CORE SCIENTIFIC INC RTS's Piotroski F-Score?

CORE SCIENTIFIC INC RTS (CORZR) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CORE SCIENTIFIC INC RTS's earnings high quality?

CORE SCIENTIFIC INC RTS (CORZR) reported a net loss of $288.6M while generating $278.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.